| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Folate, homocysteine, and negative symptoms in schizophrenia.
|
Am J Psychiatry
|
2004
|
1.65
|
|
2
|
The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis.
|
Crit Care Med
|
2011
|
1.54
|
|
3
|
Effect of hyperhomocysteinemia on protein C activation and activity.
|
Blood
|
2002
|
1.45
|
|
4
|
Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice.
|
Stroke
|
2004
|
1.37
|
|
5
|
Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation.
|
J Neurosci
|
2007
|
1.22
|
|
6
|
Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia.
|
Blood
|
2006
|
1.20
|
|
7
|
Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.11
|
|
8
|
Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice.
|
Blood
|
2003
|
1.09
|
|
9
|
Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
|
Stroke
|
2007
|
1.07
|
|
10
|
Cerebral vascular dysfunction in methionine synthase-deficient mice.
|
Circulation
|
2005
|
1.01
|
|
11
|
Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2006
|
0.99
|
|
12
|
Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice.
|
J Inherit Metab Dis
|
2012
|
0.98
|
|
13
|
Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
|
Am J Physiol Heart Circ Physiol
|
2008
|
0.97
|
|
14
|
One-carbon metabolism nutrient status and plasma S-adenosylmethionine concentrations in middle-aged and older Chinese in Singapore.
|
Int J Mol Epidemiol Genet
|
2012
|
0.96
|
|
15
|
Effects of exercise on emerging and traditional cardiovascular risk factors.
|
Prev Med
|
2004
|
0.94
|
|
16
|
Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).
|
Biochim Biophys Acta
|
2009
|
0.94
|
|
17
|
Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.
|
J Neurosci
|
2008
|
0.92
|
|
18
|
Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.
|
Circ Res
|
2009
|
0.91
|
|
19
|
Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways.
|
Mol Genet Metab
|
2010
|
0.91
|
|
20
|
Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.
|
J Neurosci
|
2012
|
0.88
|
|
21
|
Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice.
|
Mol Genet Metab
|
2013
|
0.88
|
|
22
|
Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.
|
Mol Genet Metab
|
2013
|
0.86
|
|
23
|
Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.
|
Orphanet J Rare Dis
|
2014
|
0.84
|
|
24
|
Maternal Phenylketonuria International Collaborative Study revisited: evaluation of maternal nutritional risk factors besides phenylalanine for fetal congenital heart defects.
|
J Inherit Metab Dis
|
2013
|
0.83
|
|
25
|
Plasma S-adenosylmethionine, DNMT polymorphisms, and peripheral blood LINE-1 methylation among healthy Chinese adults in Singapore.
|
BMC Cancer
|
2013
|
0.83
|
|
26
|
Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.
|
J Pediatr Hematol Oncol
|
2004
|
0.83
|
|
27
|
Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.
|
J Clin Psychiatry
|
2012
|
0.82
|
|
28
|
Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).
|
J Inherit Metab Dis
|
2014
|
0.79
|
|
29
|
Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.77
|
|
30
|
Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha.
|
Am J Physiol Endocrinol Metab
|
2009
|
0.77
|
|
31
|
Corrigendum: Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice.
|
Sci Rep
|
2017
|
0.75
|